PMID-25302294 – GHK and DNA: Resetting the Human Genome to Health
Pickart L, Vasquez-Soltero JM, Margolina A. "GHK and DNA: Resetting the Human Genome to Health," BioMed Research International, 2014;2014:151479. doi:10.1155/2014/151479
Quick Reference
| Property | Value |
|---|---|
| PMID | 25302294 |
| DOI | 10.1155/2014/151479 |
| Year | 2014 |
| Journal | BioMed Research International |
| Study Type | Narrative Review |
| Evidence Level | V |
| Sample | Gene expression analysis from Broad Institute Connectivity Map data |
| Peptide(s) Studied | GHK-Cu |
Key Findings
- GHK modulates the expression of 4,000+ human genes — approximately 6% of the human genome
- Resets gene expression of diseased cells (cancer, COPD) toward healthier patterns
- Upregulates DNA repair genes, antioxidant defense genes, and stem cell-related genes
- Suppresses genes involved in inflammation, tissue destruction, and metastasis
- Used the Broad Institute Connectivity Map (cmap) to identify genome-wide effects at 1 μM concentration
Study Design
Bioinformatic analysis using the Broad Institute Connectivity Map database. Gene expression signatures from GHK-treated cells were compared against disease-associated gene expression patterns (cancer, COPD, aging). Identified gene networks reset by GHK treatment.
Limitations
- Bioinformatic/computational analysis; not a traditional wet-lab experiment
- Gene expression changes in vitro may not translate to in vivo tissue effects
- Single concentration (1 μM) analyzed
- Pickart is the leading GHK researcher; potential for confirmation bias
Clinical Relevance
Landmark paper establishing GHK as a broad gene expression modulator. The scale of gene modulation (4000+) is exceptional among peptides. This provides the mechanistic foundation for GHK-Cu's diverse therapeutic claims — from anti-aging to anti-cancer to tissue repair. Critical reference for the GHK-Cu peptide profile.
Related
#research #narrative-review #evidence-level-V